Looking ahead, management has guided for the third quarter to see up to $313 million in revenue, representing 25% YoY growth.

The United States Food and Drug Administration plans to present data allegedly linking COVID-19 vaccinations to dozens of ...

Vaccine makers’ shares fell after a report that Trump health officials plan to link Covid shots to the deaths of around two ...